Stimulation of naïve B cells with a fusion protein consisting of FlaA and Bet v 1 induces regulatory B cells ex vivo.
Alexandra GoretzkiYen-Ju LinClara MeierBritta DornSonja WolfheimerAnnette JaminMaike SchottAndrea WangorschStefan ViethsThilo JakobStephan ScheurerStefan SchülkePublished in: Allergy (2022)
rFlaA:Betv1 can act as a thymus-independent B cell antigen, stimulating the mTOR- and MyD88-dependent differentiation of B cells displaying a regulatory phenotype, IL-10 secretion, antigen-binding antibody production, and a suppressive capacity in vitro.